| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Accounting Officer | Chief Accounting Officer
1 company
Megna Michael R is a Chief Accounting Officer at KNSA. Recent filings cover 0 purchases and 15 sales. Those positions are worth an estimated $2.3M at current prices.
Our model assigns Megna Michael R a below-average insider score of 42/100, based on 12 past trades. Over a 12-month horizon, 20.0% of those trades were profitable, with an average 12-month return of -55.2%.
Megna Michael R's largest disclosed position is in KNSA as Chief Accounting Officer, worth about $2.3M. The recent filings there lean toward selling, a net 181,041 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 3, 2026 | KNSA Kiniksa Pharmaceuticals International, Plc | Chief Accounting Officer | Sale+OE | 4,600 | $80.30 | $369,380.00 | -13.7% | - | - | |
| Apr 9, 2026 | KNSA Kiniksa Pharmaceuticals International, Plc | Chief Accounting Officer | Sell | 6,625 | $46.69 | $309,321.25 | -19.5% | +36.8% | - | |
| Oct 20, 2025 | KNSA Kiniksa Pharmaceuticals International, Plc | Chief Accounting Officer | Sale+OE | 50,490 | $38.87 | $1,962,781.45 | -65.1% | +5.2% | +113.3% | |
| Sep 3, 2025 | KNSA Kiniksa Pharmaceuticals International, Plc | Chief Accounting Officer | Sale+OE | 11,000 | $34.84 | $383,240.00 | -22.4% | +12.9% | +126.8% | |
| Aug 4, 2025 | KNSA Kiniksa Pharmaceuticals International, Plc | Chief Accounting Officer | Sale+OE | 17,000 | $32.35 | $549,950.00 | -34.0% | +13.7% | +130.6% | |
| Jun 3, 2025 | KNSA Kiniksa Pharmaceuticals International, Plc | Chief Accounting Officer | Sale+OE | 15,211 | $28.75 | $437,316.25 | -31.9% | +17.8% | +66.4% | |
| May 7, 2025 | KNSA Kiniksa Pharmaceuticals International, Plc | Chief Accounting Officer | Sale+OE | 17,647 | $26.69 | $470,998.43 | -35.2% | +23.5% | +112.7% | |
| Mar 12, 2025 | KNSA Kiniksa Pharmaceuticals International, Plc | Chief Accounting Officer | Sale+OE | 9,051 | $22.45 | $203,194.95 | -25.4% | +32.3% | +104.8% | |
| Nov 29, 2024 | KNSA Kiniksa Pharmaceuticals International, Plc | Chief Accounting Officer | Sale+OE | 8,646 | $22.45 | $194,102.70 | -24.6% | -11.1% | +92.6% | |
| Mar 1, 2024 | KNSA Kiniksa Pharmaceuticals International, Plc | Chief Accounting Officer | Sale+OE | 14,785 | $21.57 | $318,881.09 | -45.7% | -14.6% | -6.7% |